Tongxuan Medical key facts
as of Oct 2026- Developer and manufacturer of balloon dilatation catheters designed to serve the Chinese medical industry.
- Tongxuan Medical is valued at approximately $314.1M as of Oct 2026 (last reported valuation).
- It has raised $41.8M; the latest was Early Stage VC ($41.8M) in Aug 2025.
- Notable investors include Qiming Venture Partners, Zhejiang Kunxin Investment Management, Hiway Capital, Minsheng Securities Investment, Nantong Blue Bay Ventures.
- Status: Privately Held (backing).
Tongxuan Medical's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·Watch Tongxuan Medical: the Monday email on marks, rounds and moves
Tongxuan Medical funding rounds
No funding rounds for Tongxuan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Tongxuan Medical valuation
Tongxuan Medical's last reported valuation was $314 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
Tongxuan Medical investors
5 investors are on record for Tongxuan Medical, including Qiming Venture Partners, Zhejiang Kunxin Investment Management, Hiway Capital and Minsheng Securities Investment.
About Tongxuan Medical
Developer and manufacturer of balloon dilatation catheters designed to serve the Chinese medical industry. The company offers prostatic dilatation catheters and other related catheter tubing products, thereby providing the urology medical industry with advanced catheter solutions.
- Sector
- Healthcare
- HQ
- Taizhou, China
- Founded
- 2020
- Website
- tongxuanyiliao.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.